Patrick M. Sweeney & Associates’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$7M Sell
48,177
-33
-0.1% -$4.56K 3.95% 3
2026
Q2
$6.19M Buy
48,210
+153
+0.3% +$17.9K 3.56% 6
2026
Q1
$5.78M Buy
48,057
+2
+0% +$231 3.71% 5
2025
Q4
$5.06M Sell
48,055
-78
-0.2% -$7.32K 3.16% 6
2025
Q3
$4.04M Buy
48,133
+14
+0% +$1.15K 2.61% 7
2025
Q2
$3.89M Buy
48,119
+427
+0.9% +$33.9K 2.68% 7
2025
Q1
$4.28M Buy
47,692
+2
+0% +$187 3.2% 6
2024
Q4
$4.74M Sell
47,690
-99
-0.2% -$10.2K 3.55% 5
2024
Q3
$5.43M Buy
47,789
+553
+1% +$65.7K 3.99% 3
2024
Q2
$5.85M Sell
47,236
-89
-0.2% -$11.5K 4.73% 3
2024
Q1
$6.24M Buy
47,325
+87
+0.2% +$10.7K 5.14% 3
2023
Q4
$5.15M Buy
+47,238
New +$4.9M 4.71% 4

Other funds holding MRK

Patrick M. Sweeney & Associates's MRK Position: Q3 2026 in Review

Patrick M. Sweeney & Associates reduced its Merck (MRK) stake by 0.07% in Q3 2026, selling an estimated $4.56K and leaving 48,177 shares worth $7M. The position accounts for 3.95% of the portfolio, ranked #3.

Patrick M. Sweeney & Associates first reported a position in MRK in Q4 2023 and has held it in 12 quarters since. 2,434 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

  • Patrick M. Sweeney & Associates held 48,177 shares of Merck worth $7M as of Q3 2026.
  • Patrick M. Sweeney & Associates sold 33 Merck shares in Q3 2026, an estimated $4.56K.
  • Merck made up 3.95% of Patrick M. Sweeney & Associates's portfolio in Q3 2026, its #3 holding.
  • Patrick M. Sweeney & Associates first reported a position in Merck in Q4 2023 and has held it in 12 quarters since.
  • 2,434 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on Patrick M. Sweeney & Associates's 13F filing for Q3 2026, filed 22 Oct 2026.